We demonstrate that IL-6 signalling-related biomarkers (IL-6, sIL-6R, sgp130, IL-6 trans-signalling estimated by the B/T complex ratio and the FME) can predict the evolution of the disease in COVID-19 patients. This evidence concerns the gene IL6ST and COVID-19.